Chemistry News: Breaking Chemistry News, Comments and Articles. - Page: 5

American Chemical Society resource connects scientists, discoveries, chemistry & biology interface

(American Chemical Society) The American Chemical Society's (ACS') Publications Division has introduced a new website, populated with survey data provided by over 4,000 scientists, to showcase connections among research subdisciplines at the interfac...

Uranium chemistry: An actinide milestone

A complex featuring a uranium(VI) terminal nitride functional group has been isolated through mild oxidation, and shown to be highly reactive. Under photolysis, it converts into a compound that is capable of C–H bond activation.

Small-Molecule Compound Developed That Could Lead To Therapeutic Treatment For Myotonic Dystrophy

There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living human cells, an important first step t...

BMS deal is Ambrx's third pharma pact in a year

Ambrx entered into a third collaboration agreement with Bristol-Myers Squibb in which the partners will use the San Diego-based biotechnology company's protein medicinal chemistry technology to discover and develop novel antibody-drug.....

Ambrx, Bristol-Myers in ADC cancer deal

Ambrx Inc. (La Jolla, Calif.) partnered with Bristol-Myers Squibb Co. (NYSE:BMY) to discover and develop antibody-drug conjugates (ADCs) for undisclosed cancer indications. Ambrx will receive $15 million up front and research funding, as well as up t...

4th International Conference and Exhibition on Analytical & Bioanalytical Techniques

California City, CA, May 03, 2013 --(PR.com)-- Through the theme: Showcasing the Contemporary Approaches in Analytical & Bioanalytical Techniques, the conference aims in promulgating knowledge and exchange of new ideas amongst the pharmacy professionals, industrialists, and students. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world...

King of Sweden Presents Crafoord Award to Feinstein Institute Arthritis Researcher

MANHASSET, N.Y., May 3, 2013 /PRNewswire-USNewswire/ -- Peter K. Gregersen, MD, a scientist at The Feinstein Institute for Medical Research, on Thursday was awarded the prestigious Crafoord Prize for his genetic research in the area of rheumatoid arthritis. The Prize award ceremony was held at the Royal Swedish Academy of Sciences (RSAS) in the presence of Their Majesties the King and Queen of Swe...

BT For Life Sciences Launches Schrodinger Into The Cloud

IRVING, Texas, May 3, 2013 /PRNewswire/ -- BT and Schrodinger, Inc. today announced that the two companies are now working together to accelerate the process of drug discovery and development using the BT for Life Sciences cloud platform and Schrodinger's powerful scientific software applications. As part of the joint initiative, Schrodinger becomes a Strategic Member of the BT for Life Sciences...

Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates

SAN DIEGO, May 3, 2013 /PRNewswire/ -- Ambrx today entered into a collaboration agreement with Bristol-Myers Squibb (NYSE: BMY) for the discovery and development of novel antibody drug conjugates using Ambrx's protein medicinal chemistry technology. Under terms of the agreement, Ambrx will receive an upfront payment of $15 million, funding for discovery and research activities, and potential...

How do anticancer drugs work?

(University of California - Riverside) Anticancer drugs save lives and/or improve the quality of life for many cancer patients. But how do they work? Yinsheng Wang, a professor of chemistry at the University of California, Riverside, will give a fr...

Anacor Pharmaceuticals Provides Update Regarding Arbitration With Valeant Pharmaceuticals

Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that Valeant Pharmaceuticals International, Inc., or Valeant, has agreed that the launch of efinaconazole, its topical product candidate for the treatment of onychomycosis, will not occur until after the September 2013 arbitration hearing to resolve our breach of contract dispute with Valeant. As a resu...

BioLineRx's BL-7010, for the Treatment of Celiac, to be Presented at Two Leading Conferences

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that the Company was invited to deliver an oral presentation at the 2013 National Education Conference & Gluten-Free Expo, the Celiac Disease Foundation's annual conference, in Pasadena, California. Leah Klapper, Ph.D., General Manager, BioLine Innovati...

Moving Liquids with Sound Helps Identify Drug Candidates that Traditional Lab Techniques Miss

How do researchers know whether new molecules will have a positive or negative effect? How much does the technique for moving a liquid affect the results? What about testing compounds for their environmental or health impacts: Is one liquid handling process better than another when it comes to accuracy of the data? A paper published by the journal...

Pfizer's Efforts Boost Pain Therapeutics And Durect Corp.

By Bob's Stocks: Shares of Pain Therapeutics Inc (PTIE) and Durect (DRRX) rose more than 40% on Tuesday after partner Pfizer (PFE) announced it is in talks with U.S. health regulators to find a way forward on the companies' painkiller, Remoxy.The U.S. Food and Drug Administration twice declined to approve Remoxy, an abuse-resistant painkiller, on concerns about the drug's chemistry and production...

Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors

NEW YORK, May 2, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs, today announced the appointment of Thomas M. Riedhammer, Ph.D., to its Board of Directors. Dr. Riedhammer has over 35 years of ophthalmic industry experience, working for large and small pharmaceutical companies engaged...

E. O. Wilson's "Letters to a Young Scientist"

I've been reading E. O. Wilson's new book, Letters to a Young Scientist. It's the latest addition to the list of "advice from older famous scientists" books, which also includes Peter Medawar's similarly titled Advice To A Young Scientist and what is...

Seaweed From North Atlantic Is Safe To Eat

Seaweed has been eaten for thousands of years by people all over the world, and it can be considered a tasty and healthy food item. This is the conclusion from professor Ole G. Mouritsen, Department of Physics, Chemistry and Pharmacy at the Universit...

Rice's OpenStax College doubles down on free, online textbooks

(Rice University) Rice University-based publisher OpenStax College today announced plans to more than double the number of titles in its catalog of free, high-quality textbooks by 2015, thanks to a grant from the Laura and John Arnold Foundation. Mor...

Anacor Pharmaceuticals Announces Closing of $23 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Over-Allotment Option

Anacor Pharmaceuticals (NASDAQ:ANAC) announced today the completion of its underwritten public offering of 3,129,890 shares of common stock. In addition, Anacor announced that the underwriters of this offering exercised their over-allotment option in full and purchased an additional 469,483 shares of common stock. Total gross proceeds from this offering ar...

Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million

PRINCETON, N.J., May 1, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today reported results for its first quarter ended March 31, 2013.  Net revenue was $580 million, representing 9.3% growth from the first quarter of 2012.  On a GAAP basis, the company reported earnings of $0.86 per diluted share in the first quarter.  Excluding a gain on the sale of our investment in BioClin...

Analytical chemistry: Unlock your hidden strength

Mass spectrometry can be used to quantify the energy and hence the strength of hydrogen bonds

Tau Founder Dr. Timothy L. Macdonald Honored for Contributions to Virginia Bioscience

Tau Therapeutics LLC announced that founder Dr. Timothy Macdonald will be honored at Virginia Bio’s 20th Anniversary Celebration in Charlottesville on May 2nd. Virginia Bio selected Dr. Macdonald as one of 20 awardees recognized for exemplary contributions to biotechnology within the Commonwealth a

Best Sites for a Medicinal Chemist?

I'm going to be traveling today, mostly through airports without good Wi-Fi (for which read "Wi-Fi that they don't want me to pay $10 for during my 90-minute layover"). But I wanted to put out a question sent in by a reader that I think would be wort...

US-Russian Initiative in Life Science Cooperation

WASHINGTON, DC -- (Marketwired) -- 05/01/13 -- The Moscow Institute of Physics and Technology Biopharmaceutical cluster "Northern" (BPCN@MIPT), the Wisconsin Technology Innovation Initiative, Inc. (Wi2) (formed to support the University of Wisconsin School of Medicine and Public Health), and ChemDiv Research Institute announced the signing of a Memorandum of Understanding (MOU) to form a non-excl...

In search of biomarkers — the science of metabolomics in pharmacy

In our latest science article Kalliopi Dodou and Paul Whiteley take a look at the study of the small molecule metabolites found in biological fluids Still the less well known relation of the genomic and proteomic disciplines, metabolomics — the...